- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06521086
Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery
Optimizing Recovery in Trauma Patients: Integrating Enhanced Nutrition Delivery With Muscle Assessments, Functional Outcomes and Quality of Life
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, randomized, controlled trial designed to evaluate the impact of enhanced protein supplementation compared to a standard of care nutrition delivery in critically ill older adult trauma patients. Enhanced protein supplementation supports patients from ICU admission to 4-weeks post-hospital discharge, providing a comprehensive and personalized plan of care carried to completion.
Subjects will be randomized 1:1 to enhanced nutrition or control arm. Subjects randomized enhanced nutrition oral nutrition supplements (Fresenius KCAL shakes) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers.
Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass. They will also be asked to complete walking and strength tests, and surveys about quality of life.These will be done at hospital admission, day 14 or hospital discharge, and at a one month post-discharge follow-up visit.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Krista Haines, MD
- Phone Number: 919-681-3784
- Email: krista.haines@duke.edu
Study Contact Backup
- Name: Paul Wischmeyer, MD
- Phone Number: 919-681-9660
- Email: paul.wischmeyer@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Recruiting
- Duke University Hospital
-
Contact:
- Lynnette Moats
- Phone Number: 919-681-3399
- Email: lynnette.moats@duke.edu
-
Sub-Investigator:
- Krista Haines, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who are at least 45 years old and presented to the Emergency Department as a leveled trauma
- Patients who have the ability to tolerate oral nutrition
- Patients who have had a standard of care CT scan this admission
Exclusion Criteria:
- Expected withdrawal of life-sustaining treatment within 48 hours
- Traumatic Brain Injury
- Presence of lower extremity fracture(s)
- Mechanical Ventilation
- Subjects for who the Investigator would recommend a different supplement based on their medical condition.
- Prisoner
- Pregnancy for women of child-bearing potential
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Enhanced Protein Supplementation
Oral nutrition supplements (ONS) will be given, at maximum, three times per day throughout hospitalization.
Upon discharge, participants will be given 4-weeks' worth of oral supplements to take.
Adjustments may be made based on indirect calorimetry (IC) measurements.
|
Fresubin drinks will be taken up to 3 times a day throughout hospitalization and for 4 weeks after discharge.
|
|
No Intervention: Control Pathway
Standard of care nutrition delivery throughout hospitalization.
Upon discharge participants will be sent home with standard nutrition information without Indirect Calorimetry (IC) guidance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle mass as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
Baseline to one month post-discharge (approximately six weeks)
|
|
|
Change in glycogen stores as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
Baseline to one month post-discharge (approximately six weeks)
|
|
|
Change in body composition (percentage of a body's weight that is fat tissue) as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
Body composition is the percentage of a body's weight that is fat tissue.
|
Baseline to one month post-discharge (approximately six weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in six minute walk test (6MWT) distance
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
The 6MWT assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
|
Baseline to one month post-discharge (approximately six weeks)
|
|
Change in four meter gait speed
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
Four meter gait speed is the time one takes to walk four meters on a level surface.
|
Baseline to one month post-discharge (approximately six weeks)
|
|
Change in 30-second sit to stand test
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
This test measures the number of times an individual can stand from a chair with no assistance in 30 seconds.
This test is used to assess functional lower body strength.
|
Baseline to one month post-discharge (approximately six weeks)
|
|
Change in grip strength
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
Grip strength is a measure of muscular strength or the maximum force/tension generated by one's forearm muscles.
It can be used as a screening tool for the measurement of upper body strength and overall strength.
|
Baseline to one month post-discharge (approximately six weeks)
|
|
Change in quadriceps strength
Time Frame: Baseline to one month post-discharge (approximately six weeks)
|
ED (electromechanical dynamometry) can be used in either isometric or isokinetic mode.
Quadriceps strength is expressed as peak knee extensor torque, which is produced at around 60° knee flexion.
|
Baseline to one month post-discharge (approximately six weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paul Wischmeyer, MD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00114950
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Istanbul Medeniyet UniversityRecruiting
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
Clinical Trials on Nutrition Supplements - Fresubin KCAL Drinks
-
Fresenius KabiOE Clinical Trial Center (KKS) Universität Innsbruck; International Medical... and other collaboratorsTerminatedAneurysmal Subarachnoid HemorrhageAustria
-
Anna Arthur, PhDFresenius KabiNot yet recruitingHead &Amp;Amp; Neck Squamous Cell Carcinoma
-
University Hospital, Basel, SwitzerlandRecruitingMuscle Wasting in Critically IllSwitzerland
-
Alexandria UniversityCompletedHemodialysis ComplicationEgypt
-
Zdeněk ŠumníkRecruiting
-
Aalborg University HospitalCompletedOrthognathic SurgeryDenmark
-
Amsterdam UMC, location VUmcCompletedCritically IllNetherlands
-
Peking University People's HospitalCompleted
-
Maastricht University Medical CenterRaisio Nutrition Ltd.Terminated
-
Buddhist Tzu Chi General HospitalMultipower Enterprise Corp.Not yet recruitingDialysis | ESRD (End-Stage Renal Disease)